Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

Google DeepMind CEO Demis Hassabis heads Gemini and the company's AI push while gaining more power. Here's how he became ...

Google has announced the consolidation of its formerly separate AI research labs — Google Brain and DeepMind — into a new unit named Google DeepMind. The new team will spearhead groundbreaking ...

Google is also moving its Responsible AI teams from Research to DeepMind to "be closer to where the models are built and scaled." It also moved other responsibility teams into its central Trust ...

Now Google’s DeepMind division says it’s made a leap in trying to understand the code with AlphaGenome, an AI model that ...

Google Research and DeepMind have launched an AI-based healthcare platform called MedPaLM, as reported by Interesting Engineering. MedPaLM is a promising language model in the medical field so far.

Alphabet’s Google has consolidated its artificial intelligence research groups into one unit, the company’s latest move to keep from falling behind in the AI race. The change folds the Brain ...

DeepMind, Alphabet’s AI unit, has placed strict controls over the release of its research papers to maintain its competitive edge in the fast-evolving AI sector, the Financial Times reported.

In the years leading up to today’s merger, DeepMind and Google Brain both made major contributions to AI research. They developed a number of groundbreaking neural networks models that unlocked ...